Latest:
Dr. Virgo Shares the Results of the PCP/MO Barriers Study
Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Kathleen L. O'Connor, MD
Latest:
Dr. O'Connor on Ongoing Breast Cancer Research
Kathleen L. O'Connor, MD, professor, associate director of Cancer Education, Department of Molecular and Cellular Biochemistry, University of Kentucky Markey Cancer Center, discusses the ongoing research in the field of breast cancer.
Kathleen Moore, MD, MS
Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Latest:
Dr Moore on the Present Standing of PARP Inhibitors in Ovarian Cancer
Kathleen N. Moore, MD, MS, discusses the use of PARP inhibitors in patients with ovarian cancer.
Kathleen Moore, MD, MS, Stephenson Cancer Center
Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Latest:
Promising Novel Targets for Endometrial Cancer Management
Kathleen N. Moore, MD, MS
Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Latest:
Dr Moore on the Evolution of Treatment Strategies for Advanced Endometrial Cancer
Kathleen N. Moore, MD, MS, discusses how standard-of-care treatment strategies for advanced recurrent endometrial cancer have improved over time.
Kathleen N. Moore, MD, Stephenson Cancer Center
Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Latest:
Rapid Readouts: The SOLO2 / ENGOT Ov-21 Trial
Kathleen N. Moore, MD, MS, University of Oklahoma
Kathleen N. Moore, MD, MS, is an associate director of clinical research at the Stephenson Cancer Center, the director of the Oklahoma TSET Phase I Program, and a professor in the Section of Gynecologic Oncology at Oklahoma University (OU) College of Medicine, OU Health.
Latest:
Advanced Endometrial Cancer